DiGirolamo, Mario

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial

Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 947

Insulin Binding and Responsiveness in Fat Cells from Patients with Reduced Glucose Tolerance and Type II Diabetes

Lönnroth, P., Digirolamo, M., Krotkiewski, M., & Smith, U. (1983) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 74

Model of spontaneous obesity in aging male Wistar rats

Newby, F. D., DiGirolamo, M., Cotsonis, G. A., & Kutner, M. H. (1990) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 64